Loading clinical trials...

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides | Clinical Trials | Clareo Health

COMPLETEDPHASE4

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

NCT01777620•Allergan

View on ClinicalTrials.gov

Summary

This is a safety and efficacy study of BOTOX® in subjects with facial rhytides (glabellar lines and crow's feet lines).

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Glabellar lines and crow's feet lines
•No prior use of botulinum toxin therapy of any serotype for any reason

Exclusion Criteria

•Previous facial cosmetic surgery, tissue grafting, or tissue augmentation with silicone or fat or other permanent fillers
•Planning a facial cosmetic procedure during the study period
•Diagnosis of myasthenia gravis, Eaton-Lambert Syndrome, and/or amyotrophic lateral sclerosis
•Anticipated need for treatment with botulinum toxin of any serotype for any reason during the study (other than study treatment)

Locations (1)

Toronto, Ontario, Canada

Key Dates

Start Date

January 31, 2013

Primary Completion Date

May 29, 2013

Completion Date

July 31, 2013

Last Updated

April 17, 2019

Enrollment

125

ACTUAL participants

Conditions

Facial Rhytides

Interventions

onabotulinumtoxinA

BIOLOGICAL

Normal Saline

DRUG

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

NCT02176356

Facial RhytidesCrow's Feet Lines+2 more

View study

COMPLETEDPHASE3

BOTOX® in the Treatment of Upper Facial Lines in Japan

NCT01797094

Upper Facial RhytidesCrow's Feet Lines+2 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 17, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides

Inclusion Criteria

Exclusion Criteria

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

BOTOX® in the Treatment of Upper Facial Lines in Japan

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines